Skip to main content English

Publikationen Peritonealkarzinose

Meeting actual benchmarks for short- and long-term outcomes after cytoreductive surgery for peritoneal surface malignancy at a newly established academic treatment center.
Braunschmid T, Beer A, Graf A, Bhangu JS, Müller C, Argeny S, Riss S, Stift A, Bergmann M, Bachleitner-Hofmann T. Surgery. 2023 Aug;174(2):189-195. doi: 10.1016/j.surg.2023.04.044. Epub 2023 May 26.PMID: 37246126 Free article.

American Society of Peritoneal Surface Malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer. Esquivel J, Piso P, Verwaal V, Bachleitner-Hofmann T, Glehen O, González-Moreno S, Deraco M, Pelz J, Alexander R, Glockzin G. J Surg Oncol. 2014;110:777-8

Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Riss S, Mohamed F, Dayal S, Cecil T, Stift A, Bachleitner-Hofmann T, Moran B.  Eur J Surg Oncol. 2013;39:931-7